Molecular Genetics and Metabolism Reports

Papers
(The median citation count of Molecular Genetics and Metabolism Reports is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Rapid genotyping of inversion variants in Mucopolysaccharidosis type II using long-range PCR: A case report22
Corrigendum to “Evaluation of 3-O-methyldopa as a biomarker for aromatic L-amino acid decarboxylase deficiency in 7 Brazilian cases” [27/100744/2021/ pages: 1-4]21
Compound heterozygote variants: c.848A > G; p.Glu283Gly and c.890C > T; p.Ala297Val, of Isovaleric acid-CoA dehydrogenase (IVD) gene causing severe Isovaleric acidemia with hyperammonemia18
Clinical and biochemical characterization of a patient with prolidase deficiency, a rare disorder of collagen metabolism17
SCYL1 deficiency and intrafamilial variability: Two cases from Kuwait17
Long-term neuromuscular, cardiac and liver outcomes in an adult man affected with Chanarin-Dorfman syndrome16
Development of high sustained anti-drug antibody titers and corresponding clinical decline in a late-onset Pompe disease patient after 11+ years on enzyme replacement therapy15
Allan-Herndon-Dudley syndrome in a female patient and related mechanisms15
A novel, high throughput, and low-cost method for the detection of 40 amines relevant to inborn errors of metabolism, in under 60 min, using reverse phase high performance liquid chromatography12
Idiosyncratic drug-induced liver injury caused by givosiran in a patient with acute intermittent porphyria12
Efficacy results from a 12-month double-blind randomized trial of arimoclomol for treatment of Niemann-Pick disease type C (NPC): Presenting a rescored 4-domain NPC Clinical Severity Scale11
FBN2 pathogenic mutation in congenital contractural arachnodactyly with severe skeletal manifestations11
A 12-month, longitudinal, intervention study examining a tablet protein substitute preparation in the management of tyrosinemia11
Reduction of lysosome abundance and GAG accumulation after odiparcil treatment in MPS I and MPS VI models9
Stratification of patients with lysosomal acid lipase deficiency by enzyme activity in dried blood spots9
Maximal dietary responsiveness after tetrahydrobiopterin (BH4) in 19 phenylalanine hydroxylase deficiency patients: What super-responders can expect9
Distinctive accumulation of globotriaosylceramide and globotriaosylsphingosine in a mouse model of classic Fabry disease8
X-linked intellectual developmental disorder with onset of neonatal heart failure: A case report and literature review8
Newborn screening, genetic analysis, and long-term follow-up of 89 cases with short-chain acyl-CoA dehydrogenase deficiency (SCADD)8
Galactose tolerance in adults with classical galactosaemia. Considering the gaps8
Propionic acidemia in Mexico: Clinical and genotypic spectrum7
Biallelic variants in the NDUFAF6 cause mitochondrial respiratory complex assembly defects associated with Leigh syndrome in probands7
Clinical utility of urinary mulberry bodies/cells testing in the diagnosis of Fabry disease7
Patient-reported visual function outcomes agree with visual acuity and ophthalmologist-graded scoring of visual function among patients with long-chain 3-hydroxyacylcoA dehydrogenase deficiency (LCHAD7
Adult disease burden in patients with mucopolysaccharidosis type I H (Hurler syndrome): A comprehensive literature review with patient case analysis7
Fabry disease caused by the GLA p.Gly183Asp (p.G183D) variant: Clinical profile of a serious phenotype7
Impact on physical, social, and family functioning of patients with metachromatic leukodystrophy and their family members in Japan: A qualitative study6
CRISPR correction of the Finnish ornithine delta-aminotransferase mutation restores metabolic homeostasis in iPSC from patients with gyrate atrophy6
Impact of classical homocystinuria on health care resource utilization and costs in the United States: A retrospective cohort study6
BALB.NCT-Cpox is a unique mouse model of hereditary coproporphyria6
In depth profiling of dihydrolipoamide dehydrogenase deficiency in primary patients fibroblasts reveals metabolic reprogramming secondary to mitochondrial dysfunction6
Starting the conversation on gene therapy for phenylketonuria: Current perspectives of patients, caregivers, and advocates6
Newborn screening for spinal muscular atrophy in Japan: One year of experience6
The biochemical profile and dietary management in S-adenosylhomocysteine hydrolase deficiency6
Pre-analytic decrease of phenylalanine in plasma of patients with phenylketonuria treated with pegvaliase6
Diagnostic challenges in ornithine transcarbamylase deficiency lacking genetic confirmation: liver biopsy versus human induced pluripotent stem cell technology6
Identification of a novel fusion Iduronidase with improved activity in the cardiovascular system6
Novel homozygous GLDC variant causing late-onset glycine encephalopathy: A case report and updated review of the literature6
A novel double GLA gene mutation of W24R and N419D in a patient with cardiac Fabry disease6
Five years of newborn screening for Pompe, Mucopolysaccharidosis type I, Gaucher, and Fabry diseases in Oregon6
Novel compound heterozygous mutations in LEP responsible for obesity in a Chinese family5
The broad spectrum of clinical manifestations observed in three patients with L2 hydroxyglutaric aciduria spans from febrile seizures to complex dystonia5
Avalglucosidase alfa in infantile-onset Pompe disease: A snapshot of real-world experience in Italy5
Outcomes and genotype correlations in patients with mitochondrial trifunctional protein or isolated long chain 3-hydroxyacyl-CoA dehydrogenase deficiency enrolled in the IBEM-IS database5
MPS VII – Extending the classical phenotype5
Critical sample collection delayed? Urine organic acid analysis can still save the day! A new case of HMG-CoA synthase deficiency5
Clinical experience with Pegvaliase in phenylketonuria: A retrospective chart review of outcomes, safety, and dosing patterns5
Newborn screening and genetic diagnosis of 3-methylcrotonyl-CoA carboxylase deficiency in Quanzhou,China5
The diagnostic journey for patients with late-onset GM2 Gangliosidoses5
Psychosocial adaptation of children and adolescents with phenylketonuria in Korea5
LC-MS/MS-based enzyme assay for lysosomal acid lipase using dried blood spots5
Clinical characterization and genetic analysis of transient abnormal myelopoiesis without the down syndrome phenotype5
Medication adherence in Fabry patients treated with migalastat: Real world experience5
Lactic acidosis, rhabdomyolysis, and hyperammonemia: Atypical presentation in a new patient with PDE-ALDH7A1 defect5
DNAJC12 deficiency: Mild hyperphenylalaninemia and neurological impairment in two siblings5
Unexplained splenomegaly as a diagnostic marker for a rare but severe disease with an innovative and highly effective new treatment option: A case report5
GBA1 variants in Brazilian Gaucher disease patients5
Expanded inherited metabolic diseases screening by tandem mass spectrophotometry: The first report from Iran4
Characterization of a UQCRC1 variant in a patient with progressive weakness, pain and sleep issues reveals a functional mitochondrial defect restored by mitochondrial transplantation4
Clinical characteristics and somatic burden of patients with mucopolysaccharidosis II with or without neurological involvement: An analysis from the Hunter Outcome Survey4
Caregiver burden, and parents' perception of disease severity determine health-related quality of life in paediatric patients with intoxication-type inborn errors of metabolism4
DGUOK-related mitochondrial DNA depletion syndrome presenting with neonatal cholestasis without marked hyperlactatemia: A diagnostic pitfall4
Glutaric aciduria and L-2-hydroxyglutaric aciduria: Clinical and molecular findings of 35 patients from Turkey4
Cost analysis of newborn screening for spinal muscular atrophy using digital PCR vs. MLPA4
A novel frameshift variant in the SLC2A1 gene causing a mild phenotype of GLUT1 deficiency syndrome: case report4
Shared decision making between patients with Fabry disease and physicians in Japan: An online survey4
Intermittent ketogenic fasting with medium-chain triglycerides improves ataxia in COQ8A-related coenzyme Q10 deficiency: A case report4
Genetic variations in the IDUA gene in Tunisian MPS I families: Identification of a novel microdeletion disrupting substrate binding and structural insights4
Blepharoptosis in infantile onset Pompe disease: Histological findings and surgical outcomes4
Efficacy of avalglucosidase alfa on forced vital capacity percent predicted in treatment-naïve patients with late-onset Pompe disease: A pooled analysis of clinical trials4
Somatic mosaicism in the δ-aminolevulinate dehydratase gene causing late-onset porphyria with erythroid-driven pathogenesis4
Characterization of a novel exonic deletion in the GALNS gene causing Morquio A syndrome4
Cardiac manifestations in adult patients with inherited metabolic disease: A single-center experience4
New mutations identified in a case of Glycogenin-1 deficiency4
Optimizing clinical outcomes: The journey of twins with CRIM-negative infantile-onset Pompe disease on high-dose enzyme replacement therapy and immunomodulation4
Long-term experience with idursulfase beta (Hunterase) in two adolescent patients with MPS II: A case series4
Frequency of iduronate-2-sulfatase gene variants detected in newborn screening for mucopolysaccharidosis type II in Japan4
Biochemical characterization of the FH variant p.Lys414Glu reveals loss of enzymatic function and disrupted multimerization4
Pegvaliase-induced immediate hypersensitivity reaction after the discontinuation of antihistamine therapy in a patient with phenylketonuria – Case report4
Two decades of experience of the Fabry Outcome Survey provides further confirmation of the long-term effectiveness of agalsidase alfa enzyme replacement therapy4
A study of Iraqi patients with homocysteine remethylation disorders in a tertiary pediatric centre4
Effectiveness and tolerability of migalastat in adult Fabry disease: A single regional centre experience4
The mutation spectrum and ethnic distribution of Wilson disease, a review4
Clinical characteristics and interdepartmental collaboration for patients with Anderson–Fabry disease in Shiga Prefecture, Japan4
The metabolic landscape of tetrahydrobiopterin metabolism disorders in the Republic of Ireland4
Relief of nocturnal neuropathic pain with the use of cannabis in a patient with Fabry disease4
Dietetic management of adults with Classical Galactosaemia in the UK: A care consensus document4
Association of ZBTB38 gene polymorphism (rs724016) with height and fetal hemoglobin in individuals with sickle cell anemia4
Novel HCFC1 variants identified in patients with ASD/ADHD and previously unreported structural brain malformations reveal the potential for phenotypic expansion4
High incidence of null variants identified from newborn screening of X-linked adrenoleukodystrophy in Taiwan4
Natural history of inflammation and impaired autophagy in children with Gaucher disease identified by newborn screening4
A synonymous KCNJ11 variant leading to MODY13: A case report and literature review4
Neuropsychological endpoints for clinical trials in methylmalonic acidemia and propionic acidemia: A pilot study4
Overview of genetic mutations causing adrenoleukodystrophy: A case-series study3
Clinical and molecular spectrum of mucopolysaccharidosis IVA in Iraqi children: Allele-specific genotype–phenotype trends and novel GALNS variants3
Expanding the phenotype of RBCK1-associated polyglucosan body myopathy type 13
A survey on the patient journey in Fabry disease in Japan3
Generation of GLA-knockout human embryonic stem cell lines to model peripheral neuropathy in Fabry disease3
Quality of life after diet liberalization in individuals with phenylketonuria treated with Pegvaliase3
Impact of migalastat therapy on corneal deposits in a female with Fabry disease: A case report3
Corrigendum to “A new pathogenic POLG variant” [Molecular Genetics and Metabolism Reports 32 (2022) 100890]3
Acid α-glucosidase (GAA) activity and glycogen content in muscle biopsy specimens of patients with Pompe disease: A systematic review3
GNE myopathy with premature ovarian failure: Case report and review of the literature3
Clinical and biochemical phenotypes, genotypes, and long-term outcomes of individuals with galactosemia type I from a single metabolic genetics center in Alberta3
The challenge of adults with phenylketonuria who have been lost to care; a single center's attempt to reach those diagnosed with PKU over 60 years of newborn screening3
Unveiling alpha-mannosidosis in Iraqi children: A series of clinically and genetically characterized cases with novel MAN2B1 variant3
Use of dexamethasone in acute rhabdomyolysis in LPIN1 deficiency3
Identification of pathogenic GCK variants in patients with common type 2 diabetes can lead to discontinuation of pharmacological treatment3
GM2 activator deficiency: An ultra-rare disorder with a new case and review of 22 published cases3
Clinical features and GCDH gene variants in three Chinese families with glutaric aciduria type 1: A case series and literature review3
Gonadal mosaicism in GNAO1 causing neurodevelopmental disorder with involuntary movements; two additional variants3
Classic and Atypical Late Infantile Neuronal Ceroid Lipofuscinosis in Latin America: Clinical and Genetic Aspects, and Treatment Outcome with Cerliponase Alfa3
Acute profound lactic alkalosis associated with NDUFV1 compound heterozygosity in a previously healthy 6-year-old female3
Integration of deep intronic and RNA sequencing enhances molecular diagnosis in genetically unsolved Pompe cases3
Dose-intensive therapy (DIT) for infantile Pompe disease: A pilot study3
Baseline urinary ALA and PBG as criteria for starting pharmacologic prophylactic treatment in acute intermittent porphyria treated with givosiran3
Breastfeeding practices for infants with inherited metabolic disorders: A survey of registered dietitians in the United States and Canada3
Comparative study on incorporation of three recombinant human α-galactosidase A drugs (agalsidases) into cultured fibroblasts and organs/tissues of Fabry mice3
First combined analysis of SMN1, SMN2, and NAIP copy numbers in Moroccan SMA patients and their correlation with disease severity3
An unusually mild case of biotin-thiamine-responsive basal ganglia disease3
Management of patients with phenylketonuria (PKU) under enzyme replacement therapy: An Italian model (expert opinion)3
Risk of inadequate protein and micronutrient intakes in patients with PKU with an increased phe-tolerance: Impact of a micronutrient-dense protein substitute3
Navigating social determinants of health barriers in the management of phenylketonuria3
Corrigendum to “Expanding the phenotype of RBCK1-associated polyglucosan body myopathy type 1”3
Reduced α-galactosidase A activity in zebrafish (Danio rerio) mirrors distinct features of Fabry nephropathy phenotype3
Does administration of hydroxychloroquine/amiodarone affect the efficacy of enzyme replacement therapy for Fabry mice?3
Joint replacement risk is markedly increased in alkaptonuria (AKU) in those with prior arthroplasty3
A child with dilated cardiomyopathy and homozygous splice site variant in FLNC gene3
Natural history of propionic acidemia in the Amish population3
A case report of riboflavin transporter deficiency: A novel heterozygous pathogenic variant in the SLC52A3 gene3
Mutation spectrum of ATP7B gene in pediatric patients with Wilson disease in Vietnam3
Pegvaliase for the treatment of phenylketonuria: Final results of a long-term phase 3 clinical trial program3
Variable disease manifestations and metabolic management within a single family affected by ornithine transcarbamylase deficiency3
Treatment of CLN1 disease with a blood-brain barrier penetrating lysosomal enzyme3
Clinical features of two Japanese siblings of neuronal ceroid lipofuscinosis type 1 (CLN1) complicated with TypeⅡ diabetes mellitus2
Novel compound heterozygote variants: c.4193_4206delinsG (p.Leu1398Argfs*25), c.793C > A (p.Pro265Thr), in the CPS1 gene (NM_001875.4) causing late onset carbamoyl phosphate synthetase 1 deficiency2
A novel GATA3 frameshift mutation causes hypoparathyroidism, sensorineural deafness, and renal dysplasia syndrome2
Neurocognitive testing in a murine model of mucopolysaccharidosis type IIIA2
Novel mutation of IFT140 in an infant with Mainzer-Saldino syndrome presenting with retinal dystrophy2
Letter to the Editors: Concerning “Hyperleucinosis during infections in maple syrup urine disease post-liver transplantation” by Guilder et al2
Mucopolysaccharidoses: A biochemical study under limited resources2
Title Page2
Long-term administration of intravenous Trappsol® Cyclo™ (HP-β-CD) results in clinical benefits and stabilization or slowing of disease progression in patients with Niemann-Pick disease type C1: Resul2
Pyridoxine-dependent epilepsy (PDE-ALDH7A1) in adulthood: A Dutch pilot study exploring clinical and patient-reported outcomes2
A case series of Cypriot patients with CblC defect: Clinical, biochemical and molecular characteristics2
Clinical and genetic characteristics of a patient with phosphoribosyl pyrophosphate synthetase 1 deficiency and a systematic literature review2
A novel SLC17A5 variant in infantile sialic acid storage disease with hyporegenerative anemia: Neuroimaging insights and literature review2
Safety and efficacy of eliglustat combined to enzyme replacement therapy for lymphadenopathy in patients with Gaucher disease type 32
Case report: Hepatocellular carcinoma in a patient with Pyridoxamine 5-phosphate oxidase (PNPO) deficiency undergoing pyridoxal 5-phosphate (PLP) treatment2
Induced pluripotent stem cell technology as diagnostic tool in patients with suspected ornithine transcarbamylase deficiency lacking genetic confirmation2
A case study of lethal neonatal CPT II deficiency: Novel insights from genetic analysis2
Integrating enzyme assay and molecular genetic testing for early diagnosis of infantile-onset Pompe disease: A case report2
Ketogenic diet in action: Metabolic profiling of pyruvate dehydrogenase deficiency2
Leukoencephalopathy with Brain stem and Spinal cord involvement and Lactate elevation (LBSL): Report of a new family and a novel DARS2 mutation2
Clinical, genetic characteristics and outcome of four Chinese patients with Bartter syndrome type 3: Further insight into a genotype-phenotype correlation2
A retrospective analysis of metabolic control in children with PKU in the COVID-19 era2
Initial presentation, management and follow-up data of 33 treated patients with hereditary tyrosinemia type 1 in the absence of newborn screening2
Association between maternally inherited deafness, epilepsy, and intellectual disability and the m.12207G > A MT-TS2 pathogenic variant in a Japanese family2
Full recovery of vision following early and intensive hemodialysis in an 18-year-old woman with methylmalonic acidemia-related optic neuropathy2
Lysinuric protein intolerance caused by a homozygous SLC7A7 deletion and presented with hyperferritinemia and osteoporosis in two siblings2
The patients` perspective on home-based infusion: A longitudinal observational study in the German healthcare setting for patients with lysosomal storage disorders treated with enzyme replacement ther2
Ataluren-mediated nonsense variant readthrough in D-bifunctional protein deficiency: A case report2
Newborn screening for isovaleric acidemia: A case report of a Chinese patient with novel variants2
Citrin-deficient patient-derived induced pluripotent stem cells as a pathological liver model for congenital urea cycle disorders2
RNA analysis of the GALNS transcript reveals novel pathogenic mechanisms associated with Morquio syndrome A2
Cholic acid increases plasma cholesterol in Smith-Lemli-Opitz syndrome: A pilot study2
Autosomal recessive ELOVL1-related disorder presenting with severe neonatal cholestasis: A novel clinical feature?2
Focal segmental glomerulosclerosis with a mutation in the mitochondrially encoded NADH dehydrogenase 5 gene: A case report2
First reported case of adult-onset very long-chain acyl-coa dehydrogenase (vlcad) deficiency in Vietnam: a rare metabolic myopathy2
Case report of neuronopathic mucopolysaccharidosis type II: Early intracerebroventricular enzyme replacement therapy and hematopoietic cell transplantation with developmental outcomes up to 5 years of2
Clinical and molecular analysis of a novel variant in heme oxygenase-1 deficiency: Unraveling its role in inflammation, heme metabolism, and pulmonary phenotype2
α-Gal A missense variants associated with Fabry disease can lead to ER stress and induction of the unfolded protein response2
Biochemical and molecular characteristics among infants with abnormal newborn screen for very-long-chain acyl-CoA dehydrogenase deficiency: A single center experience2
Use of T1 mapping in cardiac MRI for the follow-up of Fabry disease in a pediatric population2
Serum hepcidin as a biomarker of treatment response in Gaucher disease2
Impact of COVID19 pandemic on patients with rare diseases in Spain, with a special focus on inherited metabolic diseases2
Adherence to PKU guidelines among patients with phenylketonuria: A cross-sectional national multicenter survey-based study in Argentina, Brazil, and Mexico2
Management of erythropoietic protoporphyria with cholestatic liver disease: A case report2
Low bone mineralization in phenylketonuria may be due to undiagnosed metabolic acidosis2
Understanding and modifying Fabry disease: Rationale and design of a pivotal Phase 3 study and results from a patient-reported outcome validation study2
Early diagnosis and management in Gaucher disease: A case series emphasizing the critical role of newborn screening2
Familial schwannomatosis carrying LZTR1 variant p.R340X with brain tumor: A case report2
Natural history of three late-diagnosed classic Galactosemia patients2
A new multiplex analysis of glucosylsphingosine and globotriaosylsphingosine in dried blood spots by tandem mass spectrometry2
A novel COQ7 mutation causing primarily neuromuscular pathology and its treatment options2
Lipid nanoparticle delivers phenylalanine ammonia lyase mRNA to the liver leading to catabolism and clearance of phenylalanine in a phenylketonuria mouse model2
Partial suppression of BCAA catabolism as a potential therapy for BCKDK deficiency2
Severe nonketotic hyperglycinaemia due to a synonymous variant2
Propionic Acidemia diagnosed in Amish adults and pregnancy outcomes: A case series2
A novel de novo pathogenic variant in KDM3B gene at the first Albanian case of Diets-Jongmans syndrome: DIJOS2
Successful pregnancy and childbirth without metabolic abnormality in a patient with holocarboxylase synthetase deficiency1
X-linked hypohidrotic ectodermal dysplasia associated with gastroesophageal reflux disease1
Our lives with PKU: German patient voices - “Nothing about us without us”1
Cerebral folate deficiency: A report of two affected siblings1
Cytochrome P450 genes expression in human prostate cancer1
Outcomes of cases with elevated 3-hydroxyisovaleryl carnitine report from the newborn screening program1
Challenges of managing ornithine transcarbamylase deficiency in female heterozygotes1
A case of gaucher disease with a rare complication of gaucheroma and protein-losing enteropathy1
In vitro characterization of cells derived from a patient with the GLA variant c.376A>G (p.S126G) highlights a non-pathogenic role in Fabry disease1
Neuropsychiatric and sleep study in autosomal dominant dopa-responsive dystonia1
Dysregulated DNA methylation in the pathogenesis of Fabry disease1
Outcome of two siblings with late-onset Krabbe disease following allogeneic hematopoietic stem cell transplantation: And review of literature1
Domino liver transplant from a donor with maple syrup urine disease into a recipient with phenylketonuria1
Two adult sisters with untreated phenylketonuria: Strikingly discordant clinical phenotype1
The role of genetic testing in suspected fulminant myocarditis: A case report1
Intrafamilial phenotypic variability due to a missense pathogenic variant in FBP1 gene1
The recurrent p.Glu3Lys variant in EHHADH is responsible for Fanconi syndrome with early liver dysfunction and mitochondrial abnormalities1
Renoprotective effects of SGLT2 inhibitors in patients with Fabry disease1
Acid sphingomyelinase deficiency: The clinical spectrum of 2 patients who carry the Q294K mutation and diagnostic challenges1
Oral health care knowledge among Phenylketonuria patients in the Latvian population1
Clinical presentation and molecular genetics of Iranian patients with Niemann-pick type C disease and report of 6 NPC1 gene novel variants: A case series1
Tissue-specific mitochondrial DNA, MT-TF, pathogenic variants in mitochondrial myopathies1
A neonate with ornithine aminotransferase deficiency; insights on the hyperammonemia-associated biochemical phenotype of gyrate atrophy1
Impact of hematopoietic stem cell transplantation in glycogen storage disease type Ib: A single-subject research design using 13C-glucose breath test1
Importance and application of WES in fetal genetic diagnostics: Identification of novel ASPM mutation in a fetus with microcephaly1
Identification of Multiple Sulfatase Deficiency (MSD) in newborn screening: A case study1
Improvement in quality of life and general functions in pediatric acid sphingomyelinase deficiency patients after receiving olipudase alfa: A single-center experience in Taiwan1
TANGO2 deficiency disorder in a 61-year-old male with episodic weakness, rhabdomyolysis, myotonia, and a novel missense variant1
FBXL4-related encephalomyopathic mitochondrial DNA depletion syndrome: A rare cause of hyperammonemia1
Rare genetic causes of primary microcephaly in two Saudi families identified via whole-exome sequencing: Genomic and phenotypic delineation of pathogenic CDK5RAP2 and CIT variants1
Evaluation of GLA variants detected in newborn screening for Fabry disease using biomarker analysis1
Mannose phosphate isomerase-congenital disorder of glycosylation leads to asymptomatic hypoglycemia1
Carglumic acid as a treatment for persistent hyperammonemia in carnitine-acylcarnitine translocase deficiency: A case study1
Clinical characteristics and effects of enzyme replacement therapy with elosulfase alfa in Korean patients with mucopolysaccharidosis type IVA1
Lethal neonatal acidosis: Multiomic investigation of a novel HIBCH variant as the underlying cause1
Non-invasive intravenous administration of AAV9 transducing iduronate sulfatase leads to global metabolic correction and prevention of neurologic deficits in a mouse model of Hunter syndrome1
Long-term outcomes in two adult siblings with Fucosidosis – Diagnostic odyssey and clinical manifestations1
Comment on: Lee J.Z.C. et al. Case report: Hepatocellular carcinoma in a patient with Pyridoxamine 5-phosphate oxidase (PNPO) deficiency undergoing pyridoxal 5-phosphate (PLP) treatment. Mol Genet Met1
Plasma arginine levels in arginase deficiency in the “real world”1
An 18-month-old girl with Vici syndrome: A case report study1
Impact of the Covid19 pandemic on health-related quality of life in patients with Fabry disease - implications for future care of patients with rare diseases1
Empagliflozin as treatment in glycogen storage disease type IB patients1
Growth patterns in patients with mucopolysaccharidosis VII1
Stealthy progression of type 2 diabetes mellitus due to impaired ketone production in an adult patient with multiple acyl-CoA dehydrogenase deficiency1
Real-world clinical outcomes in adult patients with Fabry disease: A 20-year retrospective observational cohort study from a single centre1
Treating the whole patient: Facilitating health care for patients facing health inequity1
Real-world treatment, dosing, and discontinuation patterns among patients treated with pegvaliase for phenylketonuria: Evidence from dispensing data1
Analysis of readability of the top web searches for pediatric inborn errors of fatty acid metabolism1
Unbalanced long-chain fatty acid beta-oxidation in newborns with cystic fibrosis and congenital hypothyroidism1
Exogenous aralar/slc25a12 can replace citrin/slc25a13 as malate aspartate shuttle component in liver1
Impact of regular physiotherapy intervention on the function and quality of life of pediatric patients diagnosed with Mucopolysaccharidosis1
Expanding the genetic spectrum of the pyruvate carboxylase deficiency with novel missense, deep intronic and structural variants1
Bilateral avascular necrosis: A rare complication of Fabry disease1
Underdiagnosis of Fabry disease in minority ethnic groups1
Translation of quality of life scale for pediatric patients with Fabry disease in Japan1
Towards genomic-Newborn Screening: Technical feasibility of Exome Sequencing starting from dried blood spots1
Effectiveness and tolerability of givosiran for the management of acute hepatic porphyria: A monocenter real-life evaluation1
Efficacy of early haematopoietic stem cell transplantation versus enzyme replacement therapy on neurological progression in severe Hunter syndrome: Case report of siblings and literature review1
A 53-week, open-label phase IIIb study of velaglucerase alfa in Chinese patients with type 1 Gaucher disease: Safety, efficacy, and pharmacokinetics1
Clinical and molecular characteristics of Chinese patients with alkaptonuria: 4-year follow-up of a pediatric patient and literature review1
1.1588048934937